CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
58 hedge funds and large institutions have $1.61B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
58
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.01B | |
| 2 | +$75.3M | |
| 3 | +$71.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.2M |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$7.32M | |
| 3 | -$3.41M | |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.82M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.61M |